Dear Colleagues,

We hope this message finds you well.

We are thrilled to announce that Journal of Kidney Cancer and VHL has been awarded an Impact Factor of 1.9 in the 2023 Journal Citation Reports™ by Clarivate, released in June 2024. Our journal ranks in the Q3 category (234th out of 322) in Oncology.

We owe this success to the unwavering support and dedication of our editorial team, reviewers, readers, and authors. Your hard work in coordinating the review process, ensuring timely communication, and facilitating publication has been vital in sharing our research with the global community.

Thank you for your continued support and the positive impact you have on our journal’s success.


Kind regards,

 Journal of Kidney Cancer and VHL

Editorial office